vancomycin has been researched along with hyaluronoglucosaminidase in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Carias, L; Goossens, H; Huang, W; Klare, I; Konstabel, C; Murray, BE; Nallapareddy, SR; Rice, LB; Rudin, S; Vael, C | 1 |
GRAY, J; WARREN, GH | 1 |
Camargo, IL; Darini, AL; Gilmore, MS | 1 |
Cui, X; Hao, Y; Li, G; Li, L; Li, Y; Liu, D; Sha, X; Wang, H; Wang, L; Zhang, K | 1 |
Aljoundi, A; Devnarain, N; Gafar, MA; Govender, T; Ibrahim, UH; Mocktar, C; Mohammed, M; Omolo, CA | 1 |
5 other study(ies) available for vancomycin and hyaluronoglucosaminidase
Article | Year |
---|---|
A potential virulence gene, hylEfm, predominates in Enterococcus faecium of clinical origin.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cross Infection; Enterococcus faecium; Genes, Bacterial; Humans; Hyaluronoglucosaminidase; Membrane Proteins; Vancomycin; Vancomycin Resistance; Virulence | 2003 |
PRODUCTION OF A POLYSACCHARIDE BY STAPHYLOCOCCUS AUREUS. II. EFFECT OF TEMPERATURE AND ANTIBIOTICS.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antimetabolites; Carbohydrate Metabolism; Erythromycin; Hyaluronoglucosaminidase; Methicillin; Muramidase; Oxacillin; Polysaccharides; Polysaccharides, Bacterial; Research; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Temperature; Trypsin; Vancomycin | 1963 |
Multilocus sequence typing and analysis of putative virulence factors in vancomycin-resistant and vancomycin-sensitive Enterococcus faecium isolates from Brazil.
Topics: Adhesins, Bacterial; Animals; Anti-Bacterial Agents; Bacterial Proteins; Brazil; Carrier State; Cross Infection; Enterococcus faecium; Feces; Gram-Positive Bacterial Infections; Hospitals; Humans; Hyaluronoglucosaminidase; Membrane Proteins; Microbial Sensitivity Tests; Species Specificity; Swine; Vancomycin; Vancomycin Resistance; Virulence Factors | 2006 |
An intelligent vancomycin release system for preventing surgical site infections of bone tissues.
Topics: Animals; Anti-Bacterial Agents; Bone and Bones; Bone Diseases; Cell Line; Chitosan; Drug Delivery Systems; Drug Implants; Drug Liberation; Female; Glycerophosphates; Hyaluronic Acid; Hyaluronoglucosaminidase; Hydrogels; Male; Mice; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection; Vancomycin | 2020 |
Enzyme-responsive biomimetic solid lipid nanoparticles for antibiotic delivery against hyaluronidase-secreting bacteria.
Topics: Anti-Bacterial Agents; Biomimetics; Hyaluronoglucosaminidase; Lipase; Methicillin-Resistant Staphylococcus aureus; Nanoparticles; Vancomycin | 2023 |